1例癫痫合并肺孢子虫肺炎的病例分析  

Case analysis of one epilepsy with pneumocystis pneumonia

作　　者：刘阳 陈超阳[1] 洪钰[3] 周颖 崔一民[1] LIU Yang;CHEN Chao-yang;HONG Yu;ZHOU Ying;CUI Yi-min(Department of Pharmacy,Peking University First Hospital,Beijing 100034,China;Department of Pharmacy,Dalian Children,s Hospital,Dalian 116012,Liaoning Province,China;Department of Pharmacy,Department of Pharmacy,The Second Hospital of Anhui Medical University,Hefei 230601,Anhui Province,China)

机构地区：[1]北京大学第一医院药学部,北京100034 [2]大连市儿童医院药学部,辽宁大连116012 [3]安徽医科大学附属第二医院药学部,安徽合肥230601

出　　处：《中国临床药理学杂志》2020年第7期851-853,共3页The Chinese Journal of Clinical Pharmacology

摘　　要：目的探讨临床药师参与1例癫痫合并肺孢子虫肺炎(PCP)的治疗体会。方法临床药师参与1例癫痫患儿疑似合并PCP的治疗过程,查阅相关文献,对PCP患儿治疗方案的合理性进行分析。结果和结论对疑似PCP患儿及时给予联磺甲氧苄啶抗感染治疗后病情好转。治疗过程中,临床药师从药学角度对治疗方案的合理性进行分析,并对患儿进行药学监护,协助临床更好地保障患儿用药的安全性和有效性。Objective To explore the experience of the clinical pharmacist in the treatment of one case of epilepsy complicated with pneumocystis pneumoniae(PCP).Methods After participating in the treatment of one child with epilepsy who was suspected to be PCP, relevant references were consulted to analyze the rationality of the formulated drug treatment program.Results and Conclusion The suspected PCP child’s conditions were improved after anti-infection treatment with sulfamethylbenzidine.Throughout the treatment process, the clinical pharmacist analyzed the rationality of the treatment plan from the pharmaceutical perspective, and carried out pharmaceutical care for the children, so as to help the clinic better ensure the safety and efficacy of the medication for children.

关 键 词：癫痫 糖皮质激素 肺孢子虫肺炎 

分 类 号：R97[医药卫生—药品]